Community-Based Outreach for People Living With Methamphetamine-Associated Cardiomyopathy
Joey Chiang1, Jaimie Pechan2, Kate Smith2
1Department of Medicine, University of Washington, Seattle, Washington, USA.
Abstract:
Methamphetamine-associated cardiomyopathy continues to grow within the United States. Although initiation of guideline-directed medical therapy and cessation of methamphetamine are cornerstones of therapy, many barriers to guideline-directed medical therapy use exist for patients with methamphetamine-associated cardiomyopathy. This paper presents a case series of patients who demonstrated profound clinical and echocardiographic improvement with engagement in a community heart failure program paired with the use of alarmed pill containers to target medication adherence.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Heart Failure Drugs: Inotropic Agents
Myocarditis II: Clinical features and Diagnostic Tests
Myocarditis I: Introduction
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System


